Why did Fiserv lead the S&P 500 today?
How did Trump’s ceasefire impact global stocks?
Why are oil prices falling after Iran strikes?
What caused Amazon’s Alexa AI upgrade backlash?
How will Mastercard’s stablecoin partnerships affect payments?
Why did McDonald’s end its partnership with Krispy Kreme?
How are Tesla robotaxis affecting federal safety scrutiny?
Novo's India Move Could Reshape The Weight-Loss Drug War With Eli Lilly
benzinga.com/markets/large-cap/25/06/46076029/novos-india-move-could-reshape-the-weight-loss-drug-war-with-eli-lilly
Novo Nordisk A/S (NYSE:NVO) has reportedly launched its weight-loss drug Wegovy (semaglutide) in India to compete with Eli Lilly And Co. (NYSE:LLY).
In March this year, U.S. pharma giant Eli Lilly launched its popular weight loss drug Mounjaro (tirzepatide) in India. It is expected to…
This story appeared on benzinga.com, 2025-06-24 14:38:34.